On Tuesday, Shares of Valeant Pharmaceuticals International, Inc. (NYSE:VRX), lost -0.73% to $101.39.
Valeant Pharmaceuticals International declared that chairman and chief executive officer J. Michael Pearson will be on a medical leave of absence, effective right away. The company’s board of directors has created an Office of the Chief Executive Officer, which will comprise Robert Chai-Onn, Executive Vice President and General Counsel, Dr. Ari Kellen, Executive Vice President and Company Group Chairman, and Robert Rosiello, Executive Vice President and Chief Financial Officer, to serve in an interim capacity.
In addition, the Board of Directors has created a Committee to oversee and support the Office of the CEO and will comprise Robert A. Ingram, Lead Independent Director, G. Mason Morfit, President, ValueAct Capital, and Howard B. Schiller, former Chief Financial Officer for Valeant.
Valeant confirmed last week that Mr. Pearson had recently been hospitalized and was being treated for a severe case of pneumonia.
Valeant Pharmaceuticals International, Inc. develops, manufactures, and markets pharmaceuticals, over-the-counter products, and medical devices worldwide. The company offers Solodyn to treat red and pus-filled pimples of acne in patients, in addition to Ziana, Acanya, Atralin, Retin- A Micro, and ONEXTON gel; Wellbutrin XL for major depressive disorder in adults; Jublia for onychomycosis of the toenails; Xenazine for chorea; Targretin for Cutaneous T-Cell Lymphoma; Arestin, a subgingival sustained-release antibiotic; and PROVENGE for the treatment of prostate cancer.
Shares of Vipshop Holdings Limited (NYSE:VIPS), declined -1.44% to $15.77, during its last trading session. The company traded total volume of 5.80 million shares as contrast to its average volume of 19.54 million shares. The company has a market value of $9.57 billion and about 99.82 million shares outstanding. During the 52-week trading session the minimum price at which share price traded, registered at $12.02 and reached to max level of $30.72.
During the current month, Wall Street analysts gave the rating about the company shares whether it is time to BUY, SELL or HOLD the shares. “16” analyst said that BUY the stock and Strong BUY signal was issued by “6” analysts. Sell rating was given by “0” analysts. Hold signal was recommended by “5” analysts. Underperform rating was given by “0” analysts.
Vipshop Holdings Limited, through its auxiliaries, operates as an online discount retailer for various brands in the People’s Republic of China. It offers a range of branded products, counting women’s apparel, such as casual wear, jeans, dresses, outerwear, swimsuits, lingerie, pajamas, and maternity clothes; men’s apparel comprising casual and smart-casual T-shirts, polo shirts, jackets, pants, and underwear; women and men shoes for casual and formal occasions; and accessories comprising of belts, jewelry, watches, and glasses for women and men.
Finally, Dick’s Sporting Goods Inc. (NYSE:DKS), ended its last trade with 1.17% gain, and closed at $35.59.
According to 19 Analysts, The short term target price has been estimated at $ 48.9.The target price could deviate by a maximum of $7.89 from the forecast price. In the near term, the target price could hit a high of $68 and a low of $ 41.
Dick’s Sporting Goods, Inc. operates as a sporting goods retailer primarily in the eastern United States. The company provides hardlines, counting sporting goods equipment, fitness equipment, golf equipment, and hunting and fishing gear products; apparel; and footwear products and accessories.
